Live
JUBLPHARMA logoJUBLPHARMAstock

Jubilant Pharmova Ltd

₹989
+0.75%
Open
₹972.8
High
₹998.15
Low
₹972.8
Volume
96.6K

Price chart

Daily close · downsampled 5-year history

2021-06-21 · ₹746.72026-06-18 · ₹985.5

Instrument details

MB Code
MBEQU1317
Type
stock
ISIN
INE700A01033
BSE
530019

Latest earnings

Q4FY26 declared

Quarter
Mar 2026
Revenue
2290 Cr
Net profit
119.3 Cr
EPS
7.52
YoY revenue
+18.73%

Price returns

Historical performance

1 day
-0.71%
1 month
-2.55%
3 months
+18.48%
1 year
-12.24%
3 years
+140.78%
5 years
+34.15%

Technicals

Indicator consensus

Bullish
29
Neutral
7
Bearish
10
RSI 54.95(Neutral)

Corporate timeline

Price chart events · 1 year

Dividend
2025-07-25
{"amount":5}
Earnings
2026-02-06
{"actualRevenue":21225000000,"estimateRevenue":20997000000,"revenueSurprise":228000000,"revenueSurprisePercent":1.085869409915702,"actualEPS":6.2,"estimateEPS":9.792,"surprise":-3.592,"surprisePercent":-36.68300653594771}
Earnings
2026-05-22
{"actualRevenue":22900000000,"estimateRevenue":22061000000,"revenueSurprise":839000000,"revenueSurprisePercent":3.803091428312407,"actualEPS":8.38,"estimateEPS":7.599,"surprise":0.7810000000000006,"surprisePercent":10.27766811422556}
Earnings
2025-10-31
{"actualRevenue":19664000000,"estimateRevenue":19661000000,"revenueSurprise":3000000,"revenueSurprisePercent":0.01525863384364987,"actualEPS":7.93,"estimateEPS":6.731999999999999,"surprise":1.198,"surprisePercent":17.79560308972074}
News
2025-10-10
{"description":"Jubilant Pharmova's subsidiary plans to invest $300M by FY28 to double sterile injectable capacity in the US. The first phase includes a $132M investment for a new production line in Spokane, increasing production from 50M to 100M vials annually.","url":"https://money.rediff.com/news/market/jubilant-pharmova-to-invest-300m-in-us/35083920251010","sentiment":"Positive","domain":"Rediff Money"}